Jubilant Ingrevia gets nod to raise Rs 600 crore via commercial papers

18 Aug 2023 Evaluate

Jubilant Ingrevia has received approval for raising of funds up to Rs 600 crore by issuance of Commercial Paper (CP). The members of the Finance Committee, at its meeting held on August 18, 2023 has considered and approved the same.  

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.


Jubilant Ingrevia Share Price

648.10 8.30 (1.30%)
10-Apr-2026 10:10 View Price Chart
Peers
Company Name CMP
BASF India 3600.50
Tata Chemicals 666.00
SRF 2427.65
Pidilite Inds. 1344.90
Deepak Nitrite 1474.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×